Target intelligence / Profile preview

TATA-box binding protein associated factor 9 pseudogene 3 (TAF9P3)

Target
TAF9P3
Molecular classification
Pseudogene, Non-protein coding genetic element
01

Overview

TATA-box binding protein associated factor 9 pseudogene 3 (TAF9P3, also called TAF2GL) is a pseudogene located on human chromosome 19[2][4][5]. Pseudogenes like TAF9P3 are DNA sequences similar to known genes but usually lack coding potential due to disabling mutations, deletions, or truncations, and do not produce functional proteins[6][8]. TAF9P3 resembles the functional gene TAF9, which encodes a 32 kDa subunit of the transcription factor IID (TFIID) complex involved in RNA polymerase II transcription initiation. While some pseudogenes are implicated in regulating their parental genes by acting as competitive endogenous RNAs (ceRNAs) or microRNA decoys that may influence gene expression[6][8], there is currently no evidence that TAF9P3 is directly involved in disease, nor is it known to code for a functional protein. TAF9P3 is not considered a receptor, enzyme, transporter, or any kind of canonical therapeutic target. Its annotation may cause confusion if interpreted as a drug target, since its only known function is as an annotated pseudogene with potential RNA-level regulatory activities, which remain unvalidated in clinical or pharmacological contexts[2][4][5][8].

Other names
TAF2GL
02

Biological functions

Putative RNA-mediated regulation through microRNA decoy effects (general for pseudogenes; specific function for TAF9P3 not established)
03

Disease associations

Other (no direct association; however, some pseudogenes can regulate gene expression and impact disease processes, although this has not specifically been shown for TAF9P3)

Beyond the preview

Go deeper on TATA-box binding protein associated factor 9 pseudogene 3 (TAF9P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor 9 pseudogene 3 (TAF9P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call